10x Genomics, Inc. TXG
65.29 USD +3.66 (+5.94%)
At closeNov 3, 2026, 4:32 PM EST
65.29 0.00 0.00%
After hours · Nov 3, 4:32 PM ET
62.51 Day range 66.19
12.80 52-week range 102.81
- YTD
- +300.31%
- 1 year
- +376.57%
Held by funds
194 US ETFs and mutual funds hold TXG · largest positions
Ownership
Held by insiders 1.44%
Held by institutions 116.20%
Float held by institutions 117.90%
Institutions 571
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.67% | 17,629,266 | 1.15B | Jun 29, 2026 |
| Blackrock Inc. | 8.99% | 10,804,070 | 705.40M | Jun 29, 2026 |
| ARK Investment Management, LLC | 8.32% | 10,003,057 | 653.10M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.81% | 6,982,492 | 455.89M | Jun 29, 2026 |
| Quantinno Capital Management, LP | 4.55% | 5,469,698 | 357.12M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.23% | 5,082,594 | 331.84M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.94% | 3,528,683 | 230.39M | Jun 29, 2026 |
| ARK ETF Trust-ARK Innovation ETF | 2.62% | 3,148,101 | 205.54M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.52% | 3,032,629 | 198.00M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.12% | 2,548,523 | 166.39M | Jun 29, 2026 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 2.08% | 2,498,429 | 163.12M | Sep 29, 2026 |
| Fidelity Select PORT.s-Select Medical Technology and Devices PORT. | 1.99% | 2,392,772 | 156.22M | Aug 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| HINDSON BENJAMIN J | President | Sale | Aug 23, 2026 | 488,182 |
| KOSARAJU SRIDHAR | Director | Stock Award(Grant) | Jun 3, 2026 | 68,278 |
| MATEO ALAN V. | Director | Stock Award(Grant) | Jun 3, 2026 | 85,877 |
| POPOVITS KIMBERLY J | Director | Stock Award(Grant) | Jun 3, 2026 | 37,445 |
| SAXONOV SERGE WILSON | Chief Executive Officer | Sale | Sep 21, 2026 | 1,335,170 |
| STUELPNAGEL JOHN R | Director | Sale | Sep 2, 2026 | 328,436 |
